NATCO PHARMA
Back to Balance Sheet
|
NATCO PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-19 Cr | ₹12 Cr | ₹30 Cr | ₹41 Cr | ₹26 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NATCO PHARMA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-19 Cr |
Mar2023 | ₹12 Cr |
Mar2022 | ₹30 Cr |
Mar2021 | ₹41 Cr |
Mar2020 | ₹26 Cr |
How is Deferred Tax Assets / Liabilities of NATCO PHARMA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-19 Cr | Negative | |
Mar2023 | ₹12 Cr | -58.80 | |
Mar2022 | ₹30 Cr | -27.12 | |
Mar2021 | ₹41 Cr | 59.46 | |
Mar2020 | ₹26 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹13,886.5 Cr | -2.8% | -4.5% | -25.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹404,900.0 Cr | -1.3% | 4.7% | 3.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹148,474.0 Cr | 1.9% | 1.5% | 41.9% | Stock Analytics | |
CIPLA | ₹118,166.0 Cr | 3.4% | 0.1% | -3.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹105,849.0 Cr | -4.8% | 1.9% | 20.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,553.6 Cr | -0.1% | -1% | -11.3% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | -2.8% |
-4.5% |
-25.2% |
SENSEX | -1.5% |
1.1% |
1.2% |
You may also like the below Video Courses